Gestational diabetes as a risk factor for GBS maternal rectovaginal colonization: a systematic review and meta-analysis.
Streptococcus agalactiae
Diabetes mellitus
Gestational diabetes
Group B Streptococcus
Neonatal outcomes
Type 1 diabetes
Type 2 diabetes
Vaginal colonization
Vaginal microbiome
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
20 Jul 2024
20 Jul 2024
Historique:
received:
03
11
2023
accepted:
12
07
2024
medline:
21
7
2024
pubmed:
21
7
2024
entrez:
20
7
2024
Statut:
epublish
Résumé
Maternal rectovaginal colonization by group B Streptococcus (GBS) increases the risk of perinatal GBS disease that can lead to death or long-term neurological impairment. Factors that increase the risk of rectovaginal GBS carriage are incompletely understood resulting in missed opportunities for detecting GBS in risk-based clinical approaches. There is a lacking consensus on whether gestational diabetes mellitus (GDM) is a risk factor for rectovaginal GBS. This systematic review and meta-analysis aims to address current conflicting findings and determine whether GDM should be clinically considered as a risk factor for maternal GBS colonization. Peer-reviewed studies that provided GDM prevalence and documented GBS vaginal and/or rectal colonization in women with and without GDM were included in this analysis. From study inception to October 30, 2023, we identified 6,275 relevant studies from EMBASE and PUBMED of which 19 were eligible for inclusion. Eligible studies were analyzed and thoroughly assessed for risk of bias with a modified Newcastle-Ottawa Scale that interrogated representativeness and comparability of cohorts, quality of reporting for GDM and GBS status, and potential bias from other metabolic diseases. Results were synthesized using STATA 18 and analyzed using random-effects meta-analyses. Studies encompassed 266,706 women from 10 different countries, with study periods spanning from 1981 to 2020. Meta-analysis revealed that gestational diabetes is associated with a 16% increased risk of rectovaginal GBS carriage (OR 1.16, CI 1.07-1.26, P = 0.003). We also performed subgroup analyses to assess independent effects of pregestational vs. gestational diabetes on risk of maternal GBS carriage. Pregestational diabetes (Type 1 or Type 2 diabetes mellitus) was also associated with an increased risk of 76% (pooled OR 1.76, CI 1.27-2.45, P = 0.0008). This study achieved a consensus among previously discrepant observations and demonstrated that gestational diabetes and pregestational diabetes are significant risk factors for maternal rectovaginal carriage of GBS. Recognition of GDM as a risk factor during clinical decisions about GBS screening and intrapartum antibiotic prophylaxis may decrease the global burden of GBS on maternal-perinatal health.
Sections du résumé
BACKGROUND
BACKGROUND
Maternal rectovaginal colonization by group B Streptococcus (GBS) increases the risk of perinatal GBS disease that can lead to death or long-term neurological impairment. Factors that increase the risk of rectovaginal GBS carriage are incompletely understood resulting in missed opportunities for detecting GBS in risk-based clinical approaches. There is a lacking consensus on whether gestational diabetes mellitus (GDM) is a risk factor for rectovaginal GBS. This systematic review and meta-analysis aims to address current conflicting findings and determine whether GDM should be clinically considered as a risk factor for maternal GBS colonization.
METHODS
METHODS
Peer-reviewed studies that provided GDM prevalence and documented GBS vaginal and/or rectal colonization in women with and without GDM were included in this analysis. From study inception to October 30, 2023, we identified 6,275 relevant studies from EMBASE and PUBMED of which 19 were eligible for inclusion. Eligible studies were analyzed and thoroughly assessed for risk of bias with a modified Newcastle-Ottawa Scale that interrogated representativeness and comparability of cohorts, quality of reporting for GDM and GBS status, and potential bias from other metabolic diseases. Results were synthesized using STATA 18 and analyzed using random-effects meta-analyses.
RESULTS
RESULTS
Studies encompassed 266,706 women from 10 different countries, with study periods spanning from 1981 to 2020. Meta-analysis revealed that gestational diabetes is associated with a 16% increased risk of rectovaginal GBS carriage (OR 1.16, CI 1.07-1.26, P = 0.003). We also performed subgroup analyses to assess independent effects of pregestational vs. gestational diabetes on risk of maternal GBS carriage. Pregestational diabetes (Type 1 or Type 2 diabetes mellitus) was also associated with an increased risk of 76% (pooled OR 1.76, CI 1.27-2.45, P = 0.0008).
CONCLUSIONS
CONCLUSIONS
This study achieved a consensus among previously discrepant observations and demonstrated that gestational diabetes and pregestational diabetes are significant risk factors for maternal rectovaginal carriage of GBS. Recognition of GDM as a risk factor during clinical decisions about GBS screening and intrapartum antibiotic prophylaxis may decrease the global burden of GBS on maternal-perinatal health.
Identifiants
pubmed: 39033123
doi: 10.1186/s12884-024-06694-7
pii: 10.1186/s12884-024-06694-7
doi:
Types de publication
Journal Article
Systematic Review
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
488Subventions
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI167547
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI173448
Organisme : NIDDK NIH HHS
ID : DK136201
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK128053
Pays : United States
Organisme : NIGMS NIH HHS
ID : GM136554
Pays : United States
Organisme : Burroughs Wellcome Fund
ID : NGP10103
Informations de copyright
© 2024. The Author(s).
Références
Gonçalves BP, Procter SR, Paul P, Chandna J, Lewin A, Seedat F, Koukounari A, Dangor Z, Leahy S, Santhanam S, et al. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 2022;10(6):e807–19.
pubmed: 35490693
pmcid: 9090904
doi: 10.1016/S2214-109X(22)00093-6
Kwatra G, Cunnington MC, Merrall E, Adrian PV, Ip M, Klugman KP, Tam WH, Madhi SA. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(9):1076–84.
pubmed: 27236858
doi: 10.1016/S1473-3099(16)30055-X
Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, Lawn JE, Baker CJ, Bartlett L, Cutland C, et al. Maternal colonization with Group B Streptococcus and serotype distribution Worldwide: systematic review and Meta-analyses. Clin Infect Dis. 2017;65(suppl2):S100–11.
pubmed: 29117327
pmcid: 5848259
doi: 10.1093/cid/cix658
Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, Hudson Jain J, Lynfield R. Epidemiology of Invasive Early-Onset neonatal Sepsis, 2005 to 2014. Pediatrics 2016, 138(6).
Hasperhoven GF, Al-Nasiry S, Bekker V, Villamor E, Kramer B. Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis. BJOG. 2020;127(6):680–91.
pubmed: 31913562
pmcid: 7187465
doi: 10.1111/1471-0528.16085
Heath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A. Group B streptococcal disease in infants: a case control study. Arch Dis Child. 2009;94(9):674–80.
pubmed: 19457879
doi: 10.1136/adc.2008.148874
Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PC, Gerards LJ, Adriaanse AH, van Lingen RA, Kollée LA. Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch Dis Child Fetal Neonatal Ed. 2007;92(4):F271–276.
pubmed: 17227807
pmcid: 2675425
doi: 10.1136/adc.2005.088799
Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, Hoegfeldt CA, Elise Powe C, Immanuel J, Karuranga S, et al. IDF Diabetes Atlas: estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Res Clin Pract. 2022;183:109050.
pubmed: 34883186
doi: 10.1016/j.diabres.2021.109050
McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.
pubmed: 31296866
doi: 10.1038/s41572-019-0098-8
McElwain CJ, McCarthy FP, McCarthy CM. Gestational diabetes Mellitus and maternal Immune Dysregulation: what we know so far. Int J Mol Sci 2021, 22(8).
Wang J, Zheng J, Shi W, Du N, Xu X, Zhang Y, Ji P, Zhang F, Jia Z, Wang Y, et al. Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus. Gut. 2018;67(9):1614–25.
pubmed: 29760169
doi: 10.1136/gutjnl-2018-315988
Cortez RV, Taddei CR, Sparvoli LG, Ângelo AGS, Padilha M, Mattar R, Daher S. Microbiome and its relation to gestational diabetes. Endocrine. 2019;64(2):254–64.
pubmed: 30421135
doi: 10.1007/s12020-018-1813-z
Håkansson S, Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997–2001. BJOG. 2006;113(12):1452–8.
pubmed: 17083655
doi: 10.1111/j.1471-0528.2006.01086.x
Medugu N, Iregbu KC, Parker RE, Plemmons J, Singh P, Audu LI, Efetie E, Davies HD, Manning SD. Group B streptococcal colonization and transmission dynamics in pregnant women and their newborns in Nigeria: implications for prevention strategies. Clin Microbiol Infect. 2017;23(9):e673679–673616.
doi: 10.1016/j.cmi.2017.02.029
Piper JM, Georgiou S, Xenakis EM, Langer O. Group B streptococcus infection rate unchanged by gestational diabetes. Obstet Gynecol. 1999;93(2):292–6.
pubmed: 9932572
Edwards JM, Watson N, Focht C, Wynn C, Todd CA, Walter EB, Heine RP, Swamy GK, Group B. Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study. Infect Dis Obstet Gynecol 2019, 2019:5430493.
Matorras R, Garcia-Perea A, Usandizaga JA, Omenaca F. Recto-vaginal colonization and urinary tract infection by group B streptococcus in the pregnant diabetic patient. Acta Obstet Gynecol Scand. 1988;67(7):617–20.
pubmed: 3073623
doi: 10.3109/00016348809004274
Ramos E, Gaudier FL, Hearing LR, Del Valle GO, Jenkins S, Briones D. Group B streptococcus colonization in pregnant diabetic women. Obstet Gynecol. 1997;89(2):257–60.
pubmed: 9015031
doi: 10.1016/S0029-7844(96)00489-9
Bey M, Pastorek Ii JG, Miller JM Jr. Group B streptococcal colonization in the diabetic gravida patient. Am J Perinatol. 1992;9(5–6):425–7.
pubmed: 1418148
doi: 10.1055/s-2007-999280
Chen X, Cao S, Fu X, Ni Y, Huang B, Wu J, Chen L, Huang S, Cao J, Yu W, Ye H. The risk factors for Group B Streptococcus colonization during pregnancy and influences of intrapartum antibiotic prophylaxis on maternal and neonatal outcomes. BMC Pregnancy Childbirth. 2023;23(1):207.
pubmed: 36973793
pmcid: 10041798
doi: 10.1186/s12884-023-05478-9
Farideh A, Abdolkarim H, Naderi Nasab M. Comparison of Group B Streptococcal colonization in the pregnant Diabetic and non-diabetic women. Acta Medica Iranica 2007, 47(2).
Siqueira F, Ferreira EM, de Matos Calderon I, Dias A. Prevalence of colonisation by group B streptococcus in pregnant patients in Taguatinga, Federal District, Brazil: a cross-sectional study. Arch Gynecol Obstet. 2019;299(3):703–11.
pubmed: 30656444
doi: 10.1007/s00404-019-05040-z
Lukic A, Napoli A, Santino I, Bianchi P, Nobili F, Ciampittiello G, Nardone MR, Santomauro M, Di Properzio M, Caserta D. Cervicovaginal bacteria and fungi in pregnant diabetic and non-diabetic women: a multicenter observational cohort study. Eur Rev Med Pharmacol Sci. 2017;21(10):2303–15.
pubmed: 28617561
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
pubmed: 22008217
pmcid: 3196245
doi: 10.1136/bmj.d5928
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
pubmed: 18436948
pmcid: 2335261
doi: 10.1136/bmj.39489.470347.AD
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
pubmed: 12111919
doi: 10.1002/sim.1186
2022–2023 World Bank Country Lending Group guidelines. https://worldpopulationreview.com/country-rankings/middle-income-countries .
Stapleton RD, Kahn JM, Evans LE, Critchlow CW, Gardella CM. Risk factors for group B streptococcal genitourinary tract colonization in pregnant women. Obstet Gynecol. 2005;106(6):1246–52.
pubmed: 16319248
doi: 10.1097/01.AOG.0000187893.52488.4b
Moraleda C, Benmessaoud R, Esteban J, López Y, Alami H, Barkat A, Houssain T, Kabiri M, Bezad R, Chaacho S, et al. Prevalence, antimicrobial resistance and serotype distribution of group B streptococcus isolated among pregnant women and newborns in Rabat, Morocco. J Med Microbiol. 2018;67(5):652–61.
pubmed: 29543148
doi: 10.1099/jmm.0.000720
Alfouzan W, Gaddar N, Dhar R, Rabaan AA. A study of group B streptococcus in pregnant women in Lebanon: prevalence, risk factors, vaginal flora and antimicrobial susceptibility. Infezioni Med. 2021;29(1):85–93.
Chen J, Fu J, Du W, Liu X, Rongkavilit C, Huang X, Wu Y, Wang Y, McGrath E. Group B streptococcal colonization in mothers and infants in western China: Prevalences and risk factors. BMC Infect Dis 2018, 18(1).
Dai W, Zhang Y, Xu Y, Zhu M, Rong X, Zhong Q. The effect of group B streptococcus on maternal and infants’ prognosis in Guizhou, China. Biosci Rep 2019, 39(12).
Furfaro LL, Nathan EA, Chang BJ, Payne MS. Group B streptococcus prevalence, serotype distribution and colonization dynamics in western Australian pregnant women. J Med Microbiol. 2019;68(5):728–40.
pubmed: 31013212
doi: 10.1099/jmm.0.000980
Huang J, Zheng L, Su Y, Wang F, Kong H, Chang Y, Xin H. Effects of group B streptococcus infection on vaginal micro-ecology and pregnancy outcomes of pregnant women in late pregnancy. Eur J Obstet Gynecol Reproductive Biology. 2021;267:274–9.
doi: 10.1016/j.ejogrb.2021.11.419
Palacios-Saucedo DC, Rivera-Morales G, Vazquez-Guillen LG, Caballero-Trejo JM, Mellado-Garcia A, Flores-Flores MC, Gonzalez-Navarro AS, Herrera- Rivera JA, Osuna-Rosales CG, Hernandez-Gonzalez LE. JA : Genomic analysis of virulence factors and antimicrobial resistance of group B Streptococcus isolated from pregnant women in northeastern Mexico. PLoS ONE 2022, 17(3 March).
Zhu Y, Huang J, Lin XZ, Chen C. Group B Streptococcus colonization in late pregnancy and invasive infection in neonates in China: a Population-based 3-Year study. Neonatology. 2019;115(4):301–9.
pubmed: 30808831
doi: 10.1159/000494133
Place K, Rahkonen L, Nupponen I, Kruit H. Vaginal streptococcus B colonization is not associated with increased infectious morbidity in labor induction. Acta Obstet Gynecol Scand. 2021;100(8):1501–10.
pubmed: 33768531
doi: 10.1111/aogs.14154
Raimer K, O’Sullivan MJ. Influence of diabetes on group B Streptococcus colonization in the pregnant patient. J Matern Fetal Med. 1997;6(2):120–3.
pubmed: 9086431
Manzanares S, Zamorano M, Naveiro-Fuentes M, Pineda A, Rodríguez-Granger J, Puertas A. Maternal obesity and the risk of group B streptococcal colonisation in pregnant women. J Obstet Gynaecol. 2019;39(5):628–32.
pubmed: 30932731
doi: 10.1080/01443615.2018.1552670
Ji Y, Zhao C, Ma XX, Peppelenbosch MP, Ma Z, Pan Q. Outcome of a screening program for the prevention of neonatal early-onset group B Streptococcus infection: a population-based cohort study in inner Mongolia, China. J Med Microbiol. 2019;68(5):803–11.
pubmed: 30994439
doi: 10.1099/jmm.0.000976
McCoy JA, Burris HH, Gerson KD, McCarthy C, Ravel J, Elovitz MA. Cervicovaginal Microbial-Immune State and Group B Streptococcus colonization in pregnancy. Am J Perinatol 2023.
Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE handbook. In.; 2013.
Stoikou M, Grimolizzi F, Giaglis S, Schäfer G, van Breda SV, Hoesli IM, Lapaire O, Huhn EA, Hasler P, Rossi SW, Hahn S. Gestational diabetes Mellitus is Associated with altered neutrophil activity. Front Immunol. 2017;8:702.
pubmed: 28659928
pmcid: 5469883
doi: 10.3389/fimmu.2017.00702
Hara Cde C, França EL, Fagundes DL, de Queiroz AA, Rudge MV, Honorio-França AC, Calderon Ide M. Characterization of Natural Killer Cells and Cytokines in Maternal Placenta and Fetus of Diabetic Mothers. J Immunol Res 2016, 2016:7154524.
Mihalic Z, Kindler O, Raftopoulou S, Santiso A, Wadsack C, Heinemann A, Kargl J. Gestational diabetes mellitus dysregulates the PD-1/PD-L1 axis at the feto-maternal interface. bioRxiv 2023:2023.2001.2025.525478.
Kang YE, Yi HS, Yeo MK, Kim JT, Park D, Jung Y, Kim OS, Lee SE, Kim JM, Joung KH, et al. Increased pro-inflammatory T cells, senescent T cells, and Immune-check point molecules in the Placentas of patients with gestational diabetes Mellitus. J Korean Med Sci. 2022;37(48):e338.
pubmed: 36513052
pmcid: 9745681
doi: 10.3346/jkms.2022.37.e338
Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019;220(4):324–35.
pubmed: 30447213
doi: 10.1016/j.ajog.2018.11.1089
Dunlop AL, Satten GA, Hu YJ, Knight AK, Hill CC, Wright ML, Smith AK, Read TD, Pearce BD, Corwin EJ. Vaginal Microbiome composition in early pregnancy and risk of spontaneous Preterm and Early Term Birth among African American Women. Front Cell Infect Microbiol. 2021;11:641005.
pubmed: 33996627
pmcid: 8117784
doi: 10.3389/fcimb.2021.641005
Tabatabaei N, Eren AM, Barreiro LB, Yotova V, Dumaine A, Allard C, Fraser WD. Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case-control study. BJOG. 2019;126(3):349–58.
pubmed: 29791775
doi: 10.1111/1471-0528.15299
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4680–7.
pubmed: 20534435
doi: 10.1073/pnas.1002611107
Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiol (Reading). 2004;150(Pt 8):2565–73.
doi: 10.1099/mic.0.26905-0
Freitas AC, Chaban B, Bocking A, Rocco M, Yang S, Hill JE, Money DM. The vaginal microbiome of pregnant women is less rich and diverse, with lower prevalence of Mollicutes, compared to non-pregnant women. Sci Rep. 2017;7(1):9212.
pubmed: 28835692
pmcid: 5569030
doi: 10.1038/s41598-017-07790-9
DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, Sun CL, Goltsman DS, Wong RJ, Shaw G, et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A. 2015;112(35):11060–5.
pubmed: 26283357
pmcid: 4568272
doi: 10.1073/pnas.1502875112
Rosen GH, Randis TM, Desai PV, Sapra KJ, Ma B, Gajer P, Humphrys MS, Ravel J, Gelber SE, Ratner AJ. Group B Streptococcus and the vaginal microbiota. J Infect Dis. 2017;216(6):744–51.
pubmed: 28934437
pmcid: 5853324
doi: 10.1093/infdis/jix395
Rafat D, Singh S, Nawab T, Khan F, Khan AU, Khalid S. Association of vaginal dysbiosis and gestational diabetes mellitus with adverse perinatal outcomes. Int J Gynaecol Obstet. 2022;158(1):70–8.
pubmed: 34561861
doi: 10.1002/ijgo.13945
Shabayek S, Abdellah AM, Salah M, Ramadan M, Fahmy N. Alterations of the vaginal microbiome in healthy pregnant women positive for group B Streptococcus colonization during the third trimester. BMC Microbiol. 2022;22(1):313.
pubmed: 36544085
pmcid: 9769055
doi: 10.1186/s12866-022-02730-8
He Z, Wu J, Xiao B, Xiao S, Li H, Wu K. The initial oral microbiota of neonates among subjects with gestational diabetes Mellitus. Front Pediatr. 2019;7:513.
pubmed: 31921726
pmcid: 6914726
doi: 10.3389/fped.2019.00513
Chen T, Qin Y, Chen M, Zhang Y, Wang X, Dong T, Chen G, Sun X, Lu T, White RA. Gestational diabetes mellitus is associated with the neonatal gut microbiota and metabolome. BMC Med. 2021;19(1):120. 3rd et al.
pubmed: 34039350
pmcid: 8157751
doi: 10.1186/s12916-021-01991-w
Mercado-Evans V, Mejia ME, Zulk JJ, Ottinger S, Hameed ZA, Serchejian C, Marunde MG, Robertson CM, Ballard MB, Ruano SH et al. Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiota. Nat Commun. 2024;15(1):1035
Field C, Bank TC, Spees CK, Germann K, Landon MB, Gabbe S, Grobman WA, Costantine MM, Venkatesh KK. Association between glycemic control and group B streptococcus colonization among pregnant individuals with pregestational diabetes. Am J Reprod Immunol. 2023;90(4):e13779.
pubmed: 37766411
doi: 10.1111/aji.13779
Pykało-Gawińska D, Zaręba-Szczudlik J, Gawiński C, Stępień A, Dobrowolska-Redo A, Malinowska-Polubiec A, Romejko-Wolniewicz E. Gestational weight gain and glycemic control in GDM patients with positive genital culture. Taiwan J Obstet Gynecol. 2021;60(2):262–5.
pubmed: 33678325
doi: 10.1016/j.tjog.2021.01.005
Bey M, Pastorek JG 2nd, Miller JM Jr. Group B streptococcal colonization in the diabetic gravida patient. Am J Perinatol. 1992;9(5–6):425–7.
pubmed: 1418148
doi: 10.1055/s-2007-999280
Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro CES, Lubarsky SL, Van Marter J. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med. 2021;384(10):895–904.
pubmed: 33704936
pmcid: 9041326
doi: 10.1056/NEJMoa2026028
Davis EM, Abebe KZ, Simhan HN, Catalano P, Costacou T, Comer D, Orris S, Ly K, Decker A, Mendez D, et al. Perinatal outcomes of two screening strategies for gestational diabetes Mellitus: a Randomized Controlled Trial. Obstet Gynecol. 2021;138(1):6–15.
pubmed: 34259458
pmcid: 8288467
doi: 10.1097/AOG.0000000000004431